Activity

The First Drug Designed To Slow Brain Destruction In Early Stages Alzheimer’s Patients Has Been Developed. The Drug, Lecanemab, Is An Antibody Engineered To Tell The Immune System To Clear Amyloid From The Brain. Many Are Hailing The Drug As Momentous, Even Though The Benefit Is Small, With The Risk Of Brain Swelling And Bleeding.

https://www.npr.org/sections/health-shots/2022/12/08/1141396375/lecanemab-alzheimer-drug-researchers-hope

The experimental drug lecanemab was able to slow down Alzheimer’s in a large study. Many researchers think the drug will become the first to help large numbers of patients.